Slu-pp-332 5mg

Buy 3 for $ each and save 5 %
Buy 5 for $ each and save 10 %
Buy 10 for $ each and save 20 %

Product Usage: This Products Are Intended For Research Chemical Only. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused, or mislabeled as a drug, food, or cosmetic.

Contact us for any information - 017000000

Slu-pp-332 5mg

Buy 3 for $ each and save 5%
Buy 5 for $ each and save 10%
Buy 10 for $ each and save 20%

Description

The Slu-pp-332 is a synthetic peptide that has been studied primarily for its potential anticancer properties. It belongs to a class of peptides designed to interfere with cancer cell growth and survival. While detailed public information on SLU-pp-332 is limited, similar peptides typically work by targeting specific cellular pathways involved in cancer progression, such as inducing apoptosis (programmed cell death) or inhibiting cell proliferation.

Description

Description

Slu-pp-332 Research Topics:

Anti-cancer Activity:
SLU-pp-332 has demonstrated potential in inhibiting cancer cell proliferation by inducing apoptosis and disrupting key signaling pathways involved in tumor growth. Its selectivity toward malignant cells makes it a promising candidate for targeted cancer therapies.
Inhibition of Metastasis:
Research indicates that SLU-pp-332 may reduce cancer cell migration and invasion, potentially limiting metastasis. This effect is believed to be mediated through the modulation of pathways related to cell adhesion and motility.
Synergistic Effects with Chemotherapy:
SLU-pp-332 has been studied in combination with traditional chemotherapeutic agents, showing enhanced efficacy in reducing tumor size and overcoming drug resistance in certain cancer types.
Improved Safety Profile:
Preclinical studies suggest that SLU-pp-332 exhibits minimal toxicity in healthy cells, offering a safer alternative to conventional cancer treatments with fewer side effects.
Potential Biomarker Modulation:
Emerging data highlights SLU-pp-332’s role in altering the expression of biomarkers associated with cancer progression, which may aid in patient stratification and treatment optimization.

All Articles And Product Information Provided On This Website Are For Informational And Educational Purposes Only.
The products offered on this website are furnished for in-vitro studies only. In-vitro studies {Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.

Related products

0